ReAlta Life Sciences Designates Andrew Miller to Board of Directors
By Karen Roman Biopharmaceutical company ReAlta Life Sciences said it appointed Andrew Miller, Ph.D., to its Board of Directors. Dr. Miller is the founder of Karuna Therapeutics, acquired by Bristol Myers Squibb for $14 billion in 2024, the company declared....